We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Supernus Pharmaceuticals Closes two Transactions to Raise $42 Million

News   Jan 09, 2012

 
Supernus Pharmaceuticals Closes two Transactions to Raise $42 Million
 
 
 

RELATED ARTICLES

Animal Venoms Aid the Search for New Medicines

News

Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.

READ MORE

Antidepressant Based on Ketamine Gets Backing from FDA Advisory Group

News

A form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. During a meeting at the US Food and Drug Administration (FDA) in Silver Spring, Maryland, an independent advisory panel voted 14-2 in favor of recommending a compound known as esketamine for use in treating depression.

READ MORE

Insights on the Role of Estrogen in Type 2 Diabetes

News

This study provides insights into the mechanism by which estrogen can decrease insulin resistance and the production of glucose, reducing incidences of Type 2 diabetes mellitus.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE